Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Glioblastoma × apixaban × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1 CNS 1

Conditions

Venous Thromboembolism 22 Neoplasms 15 Pulmonary Embolism 10 Venous Thrombosis 9 Thrombosis 6 Multiple Myeloma 4 Upper Extremity Deep Vein Thrombosis 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Myeloproliferative Disorders 2 Lymphoma 2 Intracranial Thrombosis 2 Hematologic Neoplasms 2 Carcinoma, Hepatocellular 2 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thromboprophylaxis 1 Thromboembolism 1 Thrombocytopenia 1 Thrombocythemia, Essential 1 Stomach Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Ovarian Neoplasms 1 Neoplasms, Plasma Cell 1 Mesenteric Ischemia 1 Leukemia 1 Head and Neck Neoplasms 1

Interventions

Temozolomide 405 Radiotherapy 202 Bevacizumab 156 Radiation 80 Magnetic Resonance Spectroscopy 76 Lomustine 49 Surgical Procedures, Operative 45 Carmustine 41 pembrolizumab 40 Irinotecan 38 Nivolumab 32 Specimen Handling 27 Carboplatin 27 Radiosurgery 24 Erlotinib Hydrochloride 24 Chemotherapy, Adjuvant 23 Radiotherapy, Intensity-Modulated 22 Drug Therapy 22 Aminolevulinic Acid 20 Cyclophosphamide 19 O(6)-benzylguanine 17 sargramostim 16 Radiotherapy, Conformal 15 temsirolimus 14 Granulocyte-Macrophage Colony-Stimulating Factor 14 Everolimus 14 Blood Specimen Collection 14 Vorinostat 13 Sorafenib 13 Ipilimumab 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05683808 2026-01-30

VTE-POG

University of Vermont Medical Center

Phase 2 Recruiting

CNSClassical hematology

Astrocytoma, Glioblastoma, Glioma, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡